South African firm gets US approval for AIDS drugs.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D017277:Drug Approval; D016568:Drugs, Generic; D006801:Humans; D007391:International Cooperation; D013019:South Africa; D014481:United States
D019380:Anti-HIV Agents; D016568:Drugs, Generic